This paper provides an overview of renal artery stenosis (RAS), a group of conditions characterized by narrowing of the main renal artery or its branches. It examines the two primary causes—atherosclerotic disease and fibromuscular dysplasia—along with associated risk factors and demographic patterns. The paper then surveys the range of diagnostic and screening modalities available, including ultrasonography, magnetic resonance angiography, CT scanning, angiography, and Doppler sonography, evaluating the strengths and limitations of each. It concludes by referencing an Australian study that assessed the accuracy and clinical applicability of these screening tests in large-scale practice.
Rather than a single condition, renal artery stenosis (RAS) refers to a group of diseases primarily characterized by the narrowing of the main renal artery as well as its branches. The narrowing of the artery secondary to atherosclerotic disease is most commonly seen in the fifth decade of life, although prevalence is unknown since there is no recommended or cost-effective screening mechanism. There is no gender difference in prevalence, although RAS is seen more frequently in patients with high cholesterol, cigarette smoking, high blood pressure, and diabetes, as well as those with a previous history of coronary artery disease, obesity, peripheral vascular disease, and a family history of RAS—though this familial association is more commonly observed in patients who also have atherosclerotic disease.
Renal artery stenosis can also be caused by fibromuscular dysplasia (FMD), a condition that produces non-inflammatory and non-atherosclerotic changes in any of the three layers of the arterial wall. This condition is most commonly seen in the carotid and renal arteries. FMD usually affects women younger than 50, and its cause is not fully understood.
While certain laboratory and physical examination findings can be suggestive of RAS, the diagnostic workup usually begins with ultrasonography. Ultrasound is performed to evaluate the size of the kidneys. If one kidney is significantly larger than the other, significant arterial stenosis is likely present. If the kidneys are equal in size, further diagnostic testing is required.
Considerable discussion surrounds the use of additional testing to evaluate RAS. Techniques that are more invasive than ultrasound are generally considered more accurate but carry the risk of nephrotoxicity and related deterioration of renal function. Magnetic resonance angiography (MRA) is another alternative but tends to overestimate stenosis in approximately 10% of cases. CT scanning or MRA may result in clinicians overlooking some of the more subtle findings; these methods are also expensive and availability may be limited.
It is possible to evaluate RAS via angiogram, but assessment of the degree of stenosis tends to be imprecise. Additionally, angiography does not allow a cross-sectional assessment of the stenosis, and in cases of FMD it is not possible to distinguish the different histological types—though intervention at the time of assessment remains a possibility.
Doppler sonography is able to measure the amount of blood flow and is non-invasive. It is capable of demonstrating problems with slow flow patterns and other findings that are highly suggestive of significant stenosis. However, Doppler ultrasound tends to be highly operator-dependent and the examination takes a significant amount of time. The exam may also be limited by abdominal girth, patient movement, and other physical factors.
"Australian study findings on duplex screening accuracy"
You’re 71% through this paper. Sign up to read the remaining 1 section.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.